Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7730783Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
- Microbiology & Immunology
NIH Funding · FY2024
Linked Award Amount
$1.2M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#11,735
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing James Michael Fleckenstein as a PI. Multi-PI records show the full award amount for context.
- 5R01AI170949-02R01Molecular Pathogenesis of enterotoxigenic E. coli associated enteropathy$614.2Kaward amount
- 5R01AI089894-16R01Novel Antigen Identification for an enterotoxigenic E coli vaccine$453.1Kaward amount
- 5R21AI173598-02R21Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines$155.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing James Michael Fleckenstein as a PI.
FY2024 award administered by Washington University in St. Louis (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardWashington University in St. Louis
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as James Michael Fleckenstein.